Biomarkers for early diagnosis of malignant mesothelioma : do we need another moonshot? Universiteit Gent Universiteit AntwerpenSabrina Lagniau, Kevin Lamote, Jan Van Meerbeeck, Karim Vermaelen
Volatile organic compounds as an early diagnostic tool for malignant pleural mesothelioma Universiteit GentKevin Lamote, Joris Van Cleemput, Kristiaan Nackaerts, Jan Van Meerbeeck
A breath test for diagnosing malignant pleural mesothelioma Universiteit GentKevin Lamote, Birgitta Hiddinga, Joris Van Cleemput, Kristiaan Nackaerts, Olivier Thas, Jan Van Meerbeeck
Screening tools for a high risk population: can we screen for early mesothelioma? Universiteit GentJan Van Meerbeeck, Kevin Lamote
Fibulin-3 as a biomarker for pleural mesothelioma Universiteit GentKevin Lamote, Paul Baas, Jan Van Meerbeeck
Volatile organic compounds as diagnostic tool for malignant pleural mesothelioma Universiteit GentKevin Lamote, Joris Van Cleemput, Kristiaan Nackaerts, Jan Van Meerbeeck
Volatile organic compounds and malignant pleural mesothelioma : simply breathtaking? Universiteit GentKevin Lamote
Volatile organic compounds in the breath of cystic fibrosis patients: a pilot phase Universiteit GentKevin Lamote, Jan Van Meerbeeck
Breathomics: niet-invasieve ademanalyse voor longkanker diagnose Universiteit GentKevin Lamote, Jan Van Meerbeeck
Breath analysis by ion mobility spectrometry allows discrimination of pleural mesothelioma patients from controls Universiteit GentKevin Lamote, Matthijs Vynck, Joris Van Cleemput, Olivier Thas, Kristiaan Nackaerts, Jan Van Meerbeeck